Is ICVX or RYLD a better dividend investment in 2026?

ICVX currently yields 13.06% with a 5% 5-year dividend growth rate. RYLD yields 12.39% with 5% growth. The better choice depends on your goal: ICVX offers higher current income.

What is the dividend yield difference between ICVX and RYLD?

ICVX has a forward dividend yield of 13.06% ($2.00/share annually). RYLD yields 12.39% ($1.81/share annually). The yield gap is 0.67 percentage points.

Home › Compare › ICVX vs RYLD

ICVX vs RYLD: Dividend Comparison 2026

ICVX yields 13.06% · RYLD yields 12.39%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ICVX wins by $2.0K in total portfolio value

INVESTMENT

TIME HORIZON10 years

ICVX

● Live price

13.06%

Share price

$15.31

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$47.3K

Annual income

$2,943.04

Full ICVX calculator →

RYLD

● Live price

12.39%

Share price

$14.64

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$45.3K

Annual income

$2,682.98

Full RYLD calculator →

Portfolio growth — ICVX vs RYLD

📍 ICVX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ICVX	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ICVX + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ICVX pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ICVX

Annual income on $10K today (after 15% tax)

$1,110.39/yr

After 10yr DRIP, annual income (after tax)

$2,501.58/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,053.44/yr

After 10yr DRIP, annual income (after tax)

$2,280.53/yr

At 15% tax rate, ICVX beats the other by $221.05/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ICVX + RYLD for your $10,000?

ICVX: 50%RYLD: 50%

100% RYLD50/50100% ICVX

Portfolio after 10yr

$46.3K

Annual income

$2,813.01/yr

Blended yield

6.08%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ICVX right now

ICVX

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$27.00

+76.4% upside vs current

Range: $27.00 — $27.00

Altman Z

22.6

Piotroski

3/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ICVX buys

RYLD buys

No recent congressional trades found for ICVX or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricICVXRYLD

Forward yield	13.06% ✓	12.39%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$47.3K ✓	$45.3K
Annual income after 10y	$2,943.04 ✓	$2,682.98
Total dividends collected	$21.0K ✓	$19.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: ICVX vs RYLD ($10,000, DRIP)

Year	ICVX Portfolio	ICVX Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$12,006	$1,306.34	$11,939	$1,239.34	+$67.00 → ICVX
2	$14,313	$1,465.82	$14,158	$1,382.89	+$155.00 → ICVX
3	$16,948	$1,633.07	$16,682	$1,532.59	+$266.00 → ICVX
4	$19,941	$1,807.22	$19,537	$1,687.64	+$404.00 → ICVX
5	$23,324	$1,987.33	$22,752	$1,847.20	+$572.00 → ICVX
6	$27,129	$2,172.42	$26,355	$2,010.43	+$774.00 → ICVX
7	$31,390	$2,361.53	$30,376	$2,176.45	+$1.0K → ICVX
8	$36,141	$2,553.64	$34,847	$2,344.43	+$1.3K → ICVX
9	$41,419	$2,747.79	$39,800	$2,513.54	+$1.6K → ICVX
10	$47,261	$2,943.04	$45,269	$2,682.98	+$2.0K → ICVX

ICVX vs RYLD: Complete Analysis 2026

ICVX — Stock

Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; IVX-A12, a respiratory syncytial virus (RSV) monovalent antigen candidate with RSV/human metapneumovirus (hMPV) bivalent target indication; IVX-241, a vaccine candidate with hMPV target; and IVX-411, an original receptor binding domain (RBD) sequence antigen with SARS-CoV-2 target indication and is under Phase 1/2 clinical trial. The company was incorporated in 2017 and is headquartered in Seattle, Washington.

Full ICVX Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this ICVX vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ICVX vs SCHD ICVX vs JEPI ICVX vs O ICVX vs KO ICVX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.